• As an Instructor of the Division of Clinical Immunology and Rheumatology, Dr. Aaron Silva-Sanchez focuses his research on understanding the origin and function of neonatal regulatory dendritic cells (mregDCs) and their role in controlling CD8 T cell responses.

    Dr. Silva-Sanchez graduated with a Ph.D. in Immunology from the National School of Biomedical Sciences in Mexico City. He joined UAB as a postdoctoral fellow in 2011 to work with Dr. Harry Schroeder on the study of mice with altered B cell receptor repertoire and the production of anti-DNA antibodies.

    In 2013, Dr. Silva-Sanchez joined the laboratory of Troy Randall where he researched the development and immunological impact of the inducible Bronchus-Associated Lymphoid Tissue (iBALT), a type of tertiary lymphoid structures in the lung. During this period, Dr. Silva-Sanchez also studied the pulmonary immune system of neonate mice in order to understand the immunological mechanisms responsible for increased susceptibility to viral infections during early life.

    During the Covid-19 pandemic, Dr. Silva-Sanchez formed part of the task force in charge of developing the preclinical trials for an intranasal vaccine against SARS-CoV-2 in collaboration with Dr. Frances Lund, Southeastern Biosafety Laboratory Alabama Birmingham (SEBLAB), and Altimmune, Inc.
  • Research Overview

  • Lung Immunology
    Dendritic cells
    Neonatal Immune system
    Infectious diseases
  • Education And Training

  • Doctorate Level Degree in Immunology, National Polytechnic Institute 2010
  • Master of Science in Immunology, National Polytechnic Institute 2006
  • Full Name

  • Aaron Silva Sanchez